Latest News
Launch of the GOLUP website
25th July, 2016 The European Brain Council is glad to announce the launch of the website related to the Good Off-Label Use Practices (GOLUP) Declaration. Off-label use is the practice of using a medicine outside its authorized indication. It plays an important part in some medical areas, since it can be of benefit to patients when no other treatment option [...]
Meeting of the EP Interest Group on Mental Health, Well-Being and Brain Disorders
On 13th July, the meeting of the Interest Group on mental health, well-being and brain disorders, co-organized by EBC and GAMIAN-Europe, has taken place in the European Parliament, co-chaired by the MEPs Marian Harkin and Nessa Childers. EBC’s executive director, Frédéric Destrebecq, has presented the main activities and projects of the European Brain Council, namely the Value of Treatment (VoT) [...]
The Biannual Report of the WHO at the EU mentions its collaboration with EBC
On 6 July 2016, the Biannual Report of the World Health Organization (WHO) at the EU was released. The report provides insights on the public role of WHO at the EU, and of how it pushed the public health agenda in the European Union. The European Brain Council is listed among the stakeholders with which the WHO collaborated during the last [...]
FENS Forum 2016: EBC’s participation
From 2 to 6 July, the FENS Forum 2016 has gathered together thousands of participants, world’s top experts, mid-career scientists, post-docs and students, facilitating and promoting the exchange of knowledge and neuroscience research. […]
Opportunity Now: Europe’s Mission to Innovate
The Innovation Report, a review conducted by Robert Madelin on innovation in Europe, has been published on 5th July 2016. The paper has been produced by the European Political Strategy Centre (EPSC), the European Commission's new think tank, where Madelin, former director general at DG Connect, is now adviser on innovation. In its first two sections, the report acknowledges the [...]
Health Policy in Your Country – OECD
The OECD has just released a new series in order to highlight the latest data in selected countries, to explain their health care systems and to provide key information in a clear and concise way, in just 2 pages. Each document highlights elements that are characteristic of that particular country, be it smoking, obesity, surgical interventions, consumption of antibiotics or alcohol [...]
Value of Treatment project: report from the first semester of 2016
The European Brain Council (EBC) is carrying out a new Study for 2015-2017 on the “Value of Treatment: Bridging the Early Diagnosis and Treatment Gap for Brain Disorders”. The main objective of the VoT project for brain disorders is to assess the socio-economic impact of interventions (clinical practice), or the lack thereof, and to provide evidence and tools that can assist policy [...]
European Health Parliament Closing Session
On 29th June, EBC representatives have attended the European Health Parliament's closing session, held in the European Parliament. The agenda was structured on debates about the reports and recommendations from the different working committees, namely: The committe on Antimicrobial Resistance, with the report "Tackling a global public health crisis" The Committe on Climate Change and Health, with the report "Tackling meat production and consumption" [...]
Call for abstract submission – Belgian Brain Council
In view of the 6th edition of the Belgian Brain Council's Congress that is going to take place on the 8th of October in Mons, a call for abstracts submission is open. At the BBC congress, clinicians, researchers, representatives of patients and pharmaceutical industry interact in the largest national meeting on Brain and Brain Disorders. The aim being to fill the [...]
EFNA Annual Partners Meeting
The Annual Partners Meeting of EFNA was held on 22 June in Brussels. It was preceded by a meeting of the European Parliament interest group on Brain, Mind and Pain, focused on the need for patient involvement in research. The issue was addressed from the patients', researchers' and industry's perspective. The EFNA Annual Meeting was the occasion for EFNA and its members to [...]